|
|
| | Propanoic acid, 2-[3-[[5-[[[(1S)-1-[4-(1,1-dimethylethyl)phenyl]ethyl]amino]carbonyl]-2,3-dimethyl-1H-indol-1-yl]methyl]phenoxy]-2-methyl- Basic information |
| | Propanoic acid, 2-[3-[[5-[[[(1S)-1-[4-(1,1-dimethylethyl)phenyl]ethyl]amino]carbonyl]-2,3-dimethyl-1H-indol-1-yl]methyl]phenoxy]-2-methyl- Chemical Properties |
| Boiling point | 760.1±60.0 °C(Predicted) | | density | 1.12±0.1 g/cm3(Predicted) | | pka | 3.27±0.10(Predicted) |
| | Propanoic acid, 2-[3-[[5-[[[(1S)-1-[4-(1,1-dimethylethyl)phenyl]ethyl]amino]carbonyl]-2,3-dimethyl-1H-indol-1-yl]methyl]phenoxy]-2-methyl- Usage And Synthesis |
| Uses | Anticancer agent 183 (example 48) is a non-agonistic PPARG modulator. Anticancer agent 183 has a high affinity to PPARG (PPARγ). Anticancer agent 183 inhibits kinase-mediated phosphorylation of PPARG. Anticancer agent 183 can used for research on metabolic diseases to avoid side effects[1]. | | IC 50 | PPAR-γ | | References | [1] Theodore Mark Kamenecka, et al. N-benzylindole modulators of pparg. 2012. |
| | Propanoic acid, 2-[3-[[5-[[[(1S)-1-[4-(1,1-dimethylethyl)phenyl]ethyl]amino]carbonyl]-2,3-dimethyl-1H-indol-1-yl]methyl]phenoxy]-2-methyl- Preparation Products And Raw materials |
|